Volume 36, Issue 143 (August 2023)                   IJN 2023, 36(143): 256-269 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ahmadi L, Haririan H, Hassankhani H. Relationship Between Treatment Adherence and the Risk of Cardiovascular Diseases Among Patients With Coronary Artery Stents. IJN 2023; 36 (143) :256-269
URL: http://ijn.iums.ac.ir/article-1-3711-en.html
1- Department of Medical Surgical Nursing, School of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran.
2- Department of Medical Surgical Nursing, School of Nursing and Midwifery, Tabriz University of Medical Sciences, Tabriz, Iran. , houman.haririan@gmail.com
Full-Text [PDF 5305 kb]   (182 Downloads)     |   Abstract (HTML)  (2199 Views)
Full-Text:   (126 Views)
Introduction
The prevalence of cardiovascular diseases (CVD) has been increasing. They are the leading cause of death in the world. In Iran, CVDs have been the most important cause of death in the last two decades, and it is expected that they will account for 44.8% of death cases in Iran by 2030. The most common CVDs is coronary artery disease (CAD), which is mainly characterized by the narrowing or blockage of the coronary arteries due to atherosclerosis. There are some methods to treat CAD, including coronary artery bypass graft, coronary angioplasty, and drug therapy. After having coronary angioplasty, patients often worry about changes in their lifestyle, lack of self-care knowledge (activity level, diet, medications, and the drug side effects), and lack of awareness about the methods that can improve their self-care skills. This indicates the need to measure their treatment adherence. To assess the risk of CVDs, a diagnostic tool is needed to identify people at risk. One of the available and common tools is the Framingham risk score (FRS). Treatment adherence is the main concern of physicians and nurses, especially in patients with heart disease who needs adhere to the prescribed treatment for a long time. This study aims to determine the relationship between treatment adherence and the risk of CVDs in patients with CAD. 

Methods
This is a descriptive cross-sectional study conducted from June to August 2021. The study population includes all male and female patients with coronary artery stents referred to Shahid Madani Hospital in Tabriz, Iran. Of these, 200 were randomly selected for the study. Inclusion criteria were having coronary stent, at least three months of stent placement. The exclusion criteria were unwillingness to continue participating in the study, being unavailable (change of location), or death. The data collection tools included a demographic form, treatment adherence questionnaire, and FRS. The data analysis was performed in SPSS software, version 22.

Results
The mean age of the patients was 61.6±10.62. The majority of them were male (60.5%) and all of them had a history of re-hospitalization. The overall mean score of treatment adherence was 41.50±8.48, indicating moderate adherence. In terms of diet and regular physical activity, patients’ adherence was poor. The mean FRS was 19.50±4.84 for women and 14.35±3.88 for for men. Overall, there was a significant relationship between treatment adherence and the risk of CVDs in patients, such that the risk of CVDs in the next 10 years among patients decreases with increasing their adherence to treatment (r=-0.25, P<0.001).

Conclusion
The treatment adherence of patients with coronary artery stents in Tabriz, Iran is at a moderate level. Their poor treatment adherence was in high fat consumption and regular exercise. Male patients (about 16%) with coronary artery stents are twice more than women (about 8%) at risk of CVDs in the next ten years. There is a significant relationship between treatment adherence and the risk of CVDs in these patients.

Ethical Considerations
Compliance with ethical guidelines

This study was approved by the ethics committee of Tabriz University of Medical Sciences (Code: IR.TBZMED.REC.1399.1027).

Funding
This research was funded by Tabriz University of Medical Sciences (Grant No.: 65875)

Authors' contributions
Study Design: Leila Ahmadi and Hamidreza Haririan; Data Gathering: Leila Ahmadi; Data Analysis: Leila Ahmadi, Hamidreza Haririan, Hadi Hassankhani; Article Writing: Hamidreza Haririan. 

Conflict of interest
The authors declared no conflict of interest.

Acknowledgments
The authors would like to thank all the patients who participated in this study for their cooperation.


Refrences
  1. Sarrafzadegan N, Mohammmadifard N. Cardiovascular disease in Iran in the last 40 years: Prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019; 22(4):204-10. [PMID]
  2. WHO. What are cardiovascular diseases? Genava: WHO; 2021.
  3. Benjamin I, Griggs RC, Andreoli TE, Fitz JG. Andreoli and carpenter's cecil essentials of medicine E-Book. Amsterdam: Elsevier Health Sciences; 2010. [Link]
  4. Khan SQ, Ludman PF. Percutaneous coronary intervention. Medicine. 2022; 50(7):437-44. [DOI:10.1016/j.mpmed.2022.04.008]
  5. Hannan EL, Zhong Y, Krumholz H, Walford G, Holmes DR Jr, Stamato NJ, et al. 30-day readmission for patients undergoing percutaneous coronary interventions in New York state. JACC Cardiovasc Interv. 2011; 4(12):1335-42. [DOI:10.1016/j.jcin.2011.08.013] [PMID]
  6. Verdoia M, Negro F, Kedhi E, Suryapranata H, Marcolongo M, De Luca G. Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: A comprehensive meta-analysis of 45 randomized trials. Vascul Pharmacol. 2021; 138:106859. [DOI:10.1016/j.vph.2021.106859] [PMID]
  7. Corones K, Coyer FM, Theobald KA. Exploring the information needs of patients who have undergone PCI. Br J Cardiac Nurs. 2009; 4(3):123. [DOI:10.12968/bjca.2009.4.3.40047]
  8. Daie M, Zayghami R, Arjeini Z, Alipour Heidari M. [The effect of continuous care model on quality of life of patient after coronary angioplasty in BOU Ali Sina hospital (Persian)]. Evid Based Care J. 2014; 4(1):61-70. [DOI:10.22038/EBCJ.2014.2396]
  9. Santo K, Singleton A, Rogers K, Thiagalingam A, Chalmers J, Chow CK, et al. Medication reminder applications to improve adherence in coronary heart disease: A randomised clinical trial. Heart. 2019; 105(4):323-9. [DOI:10.1136/heartjnl-2018-313479] [PMID]
  10. Gast A, Mathes T. Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst Rev. 2019; 8(1):112. [DOI:10.1186/s13643-019-1014-8] [PMID]
  11. Virani SS, Smith SC Jr, Stone NJ, Grundy SM. Secondary prevention for atherosclerotic cardiovascular disease: Comparing recent US and European guidelines on dyslipidemia. Circulation. 2020; 141(14):1121-3. [DOI:10.1161/CIRCULATIONAHA.119.044282] [PMID]
  12. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive accuracy of the ‘Framingham’s general CVD algorithm’ in a Middle Eastern population: Tehran Lipid and Glucose Study. Int J Clin Pract. 2011; 65(3):264 -73.  [DOI:10.1111/j.1742-1241.2010.02529.x] [PMID]
  13. Räber L, Wohlwend L, Wigger M, Togni M, Wandel S, Wenaweser P, et al. Five-year clinical and angiographic outcomes of a randomized comparison of sirolimus-eluting and paclitaxel-eluting stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE trial. Circulation. 2011; 123(24):2819-28. [DOI:10.1161/CIRCULATIONAHA.110.004762] [PMID]
  14. Ghias M, Sahebalzamani M, Farahani H, Adhami Moghadam F. [Treatment plans adherence of patients underwent coronary artery bypass graft surgery in Tehran’s Social Security Hospitals (Persian)]. Med Sci J Islamic Azad Univ. 2019; 29(3):259-66. [Link]
  15. Heydari A, Ziaee E, Ebrahimzade S. [The frequency of rehospitalization and its contributing factors in patient with cardiovascular diseases hospitalized in selected Hospitals in Mashhad in 2010 (Persian)]. Intern Med Today. 2011; 17(2):65-71. [Link]
  16. Sohn C, Kim J, Bae W. The framingham risk score, diet, and inflammatory markers in Korean men with metabolic syndrome. Nutr Res Pract. 2012; 6(3):246-53. [DOI:10.4162/nrp.2012.6.3.246] [PMID]
  17. Bitton A, Gaziano TA. The framingham heart study’s impact on global risk assessment. Prog Cardiovasc Dis. 2010; 53(1):68-78. [DOI:10.1016/j.pcad.2010.04.001] [PMID]
  18. Guerra-Silva NM, Santucci FS, Moreira RC, Massao Tashima C, de Melo SC, Pereira LR, et al. Coronary disease risk assessment in men: Comparison between ASCVD Risk versus Framingham. Int J Cardiol. 2017; 228:481-7. [DOI:10.1016/j.ijcard.2016.11.102] [PMID]
  19. Dianati M, Mahdavinejad B, Taghadosi M. [Medication adherence rate and related factors in patients with acute coronary syndrome after discharge from Shahid Beheshti Hospital in Kashan during 2017-2018 (Persian)]. Feyz Med Sci J. 2019; 23(2):201-8. [Link]
  20. Tanharo D, Ghods R, Pourrahimi M, Abdi M, Aghaei S, Vali N. [Adherence to treatment in diabetic patients and its affecting factors (Persian)]. Pajouhan Sci J. 2018; 17(1):37-44. [DOI:10.21859/psj.17.1.37]
  21. Abbaszadeh M, Rejeh N, Tadrisi SD, Jafari F. Medication adherence in patients undergoing repeat angioplasty: A cross-sectional study. J Crit Care Nurs. 2021; 14(4):41. [Link]
  22. Zare S, Shams M, Fararouei M, Shariatinia S. [Antihypertensive drugs adherence in heart disease patients referring to the Imam Reza Clinic in Shiraz (Persian)]. Sadra Med J. 2018; 6(2):151-60. [Link]
  23. Allahbakhshian A, Nazif R, Ghahramanian A, Tabrizi FJ, Ostovar S. Predictors of Iranian patients’ medication adherence after coronary angioplasty. Crescent J Med Biol Sci. 2021; 8(2):144-50. [Link]
  24. Dehghanzadeh S, Jafaraghaee F, Shishegaran M. [Compliance and associated factors in patients with chronic heart failure (Persian)]. Iran J Nurs Res. 2015; 9(4):36-46. [Link]
  25. Jani M, Salehi B, Aleyasin SA, Davoudi H. [The effectiveness of cognitive behavioral group therapy on quality of life of cardiovascular patients (Persian)]. J Arak Univ Med Sci. 2017; 20(3):22-30. [Link]
  26. Alibrahim B, Sharaheeli J, Alassaf L, Abd-Ellatif EE. Risk assessment of cardiovascular disease among adults attending primary healthcare centers in Riyadh City 2015. Cureus. 2022; 14(12):e32503. [DOI:10.7759/cureus.32503]
  1. Nikfarjam MR, Mohammadkhani S, Moradi AR, Davarpasand T. [The effect of the quality of doctor-patient relationship on medical adherence in patients with hypertension in Tehran Heart Center, Iran (Persian)]. J Health Syst Res. 2018; 14(1):11-6. [Link]
  2. Khatib R, Marshall K, Silcock J, Forrest C, Hall AS. Adherence to coronary artery disease secondary prevention medicines: Exploring modifiable barriers. Open Heart. 2019; 6(2):e000997. [DOI:10.1136/openhrt-2018-000997] [PMID]
  3. Bikmoradi A, Masmouei B, Ghomeisi M, Roshanaei G. Impact of Tele-nursing on adherence to treatment plan in discharged patients after coronary artery bypass graft surgery: A quasi-experimental study in Iran.Int J Med Inform. 2016; 86:43-8. [DOI:10.1016/j.ijmedinf.2015.12.001] [PMID]
  4. Ghorbanimoghadam Z, Vagharseyyedin SA, Zarei B, Moezi SA, Tabiee S. [The effect of educational program based on information, motivation and behavioral skills model on adherence to treatment in patients after coronary angioplasty (Persian)]. J Nurs Educ. 2022; 11(4):82-93. [Link]


 
Type of Study: Research | Subject: nursing
Received: 2023/07/12 | Accepted: 2023/08/23 | Published: 2023/09/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2015 All Rights Reserved | Iran Journal of Nursing

Designed & Developed by : Yektaweb